GTS Securities’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,741
| Closed | -$316K | – | 1842 |
|
|
2024
Q3 | $316K | Sell |
2,741
-5,177
| -65% | -$596K | ﹤0.01% | 1300 |
|
|
2024
Q2 | $1.09M | Buy |
+7,918
| New | +$1.09M | ﹤0.01% | 596 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1838 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1865 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1728 |
|